U.S. Entertainment Stock News

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...

Hamilton Insurance Group (HG) is back on investors’ radar after reporting fourth quarter and full year 2025 results, declaring a special dividend of $2.00 per share and attracting renewed attention from Wall Street research desks. See our latest analysis for Hamilton Insurance Group. At a share price of $31.59, Hamilton Insurance Group has seen a 30 day share price return of 13.84% and a year to date share price return of 15.84%. The 1 year total shareholder return of 61.50% points to strong...

EPR Properties recently reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$182.95 million for the quarter and US$718.36 million for the year, a swing to quarterly net income of US$66.9 million, and announced a 5.1% increase in its annualized common dividend to US$3.72 per share alongside updated 2026 earnings guidance. The company also continued reshaping its business with additional experiential real estate acquisitions, new debt and equity financing...

Oncolytics Biotech (NasdaqCM:ONCY) has completed patient enrollment in its Phase 1/2 GOBLET study. The company is moving ahead with pivotal trials in squamous cell anal cancer and metastatic colorectal cancer. Management is shifting clinical focus and resources toward these rare cancer indications and planning FDA interactions related to potential approval pathways. Oncolytics Biotech focuses on cancer therapies, and the GOBLET study sits at the center of that effort. With enrollment now...

If you are wondering whether Synopsys at around US$414 a share still makes sense for your portfolio, starting with a clear view of what you are paying for is essential. The stock is currently below recent levels, with a 5.9% decline over the last 7 days, 11.0% over 30 days, a 13.8% decline year to date and a 9.5% decline over 1 year, while the 3 year and 5 year returns sit at 12.7% and 81.7% respectively. These moves have put valuation back in focus for many investors, especially given...

Daktronics (NasdaqGS:DAKT) has agreed to supply an integrated digital display system across the OCVIBE campus, a large mixed-use development project. The company also announced an executive leadership change, with the former Interim President and CEO moving into an advisory role. Both updates relate to Daktronics' positioning in large commercial installations and its ongoing leadership structure. Daktronics focuses on electronic scoreboards, digital signage, and large-format LED video...

In late February 2026, Pravati Capital announced a partnership with SEI Investments' SEI Access™ marketplace to make litigation finance available as an alternative investment option for registered investment advisors and financial professionals through an end-to-end platform. Around the same time, SEI reported quarterly revenue of US$607.9 million, up 9.1% year on year and slightly above analyst expectations, with management highlighting disciplined execution and broad-based strength across...

Pitney Bowes recently reported past fourth-quarter and full-year 2025 results showing higher profitability despite lower revenue, while also affirming a US$0.09 quarterly dividend and completing a share buyback of 37,039,845 shares for US$390.77 million. Alongside these actions, the company filed a mixed shelf registration and launched a US$200 million 7.250% senior unsecured notes due 2029 offering, highlighting an active approach to balance sheet and capital planning. We’ll now examine how...

Reliance, Inc. (NYSE:RS) raised its quarterly dividend. The company is continuing its long term share buyback program. Both actions reflect management’s current approach to capital allocation and shareholder distributions. Reliance, Inc. (NYSE:RS) operates in the metals service center space, supplying processed metal products to a wide range of end markets. In that kind of business, decisions around dividends and buybacks can matter as much to investors as day to day price moves for steel...

Hilton Worldwide Holdings (HLT) is drawing attention after standing out in a hotel sector facing margin pressure, as investors weigh its resilient demand, net unit growth, RevPAR trends, and expanding international footprint. See our latest analysis for Hilton Worldwide Holdings. At a share price of US$311.78, Hilton’s recent pullback, with a 1-day share price return decline of 1.90% and a 7-day share price return decline of 1.32%, contrasts with its 30-day and 90-day share price returns of...

VEON and ride hailing operator Hala have signed a Memorandum of Understanding to expand mobility services in frontier markets. The partnership aims to combine Hala's ride hailing capabilities with VEON's digital platforms and local presence. The agreement builds on VEON's existing mobility offerings and Hala's scale in Dubai to broaden VEON's digital ecosystem beyond telecom. NasdaqGS:VEON currently trades at $55.89, with a return of 24.9% over the past year and a very large gain over three...

Boston Beer Company (SAM) has given investors fresh 2026 earnings guidance after releasing its 2025 results, pairing lower volumes and sales with gross margin gains, cost efficiencies, and ongoing share repurchases. See our latest analysis for Boston Beer Company. The 90 day share price return of 15.28% and 30 day gain of 6.16% suggest improving momentum into the latest results. However, the 1 year total shareholder return of a 6.97% decline and 5 year total shareholder return of a 79.16%...

Stride (LRN) is back in focus after quarterly results came in ahead of expectations, supported by a one-time gain. Management reaffirmed revenue guidance and raised its adjusted operating income outlook, easing concerns about earlier platform issues. See our latest analysis for Stride. Stride's share price is now US$84.38 after a 34.75% 90 day share price return and a 30.60% year to date share price return. The 1 year total shareholder return of 38.32% contrasts with a 5 year total...

If you are wondering whether Chipotle Mexican Grill’s current share price lines up with its underlying worth, you are not alone. This article will help you size up what you are really paying for. Chipotle’s stock closed at US$37.22 most recently, with returns of a 0.9% decline over 7 days, 4.2% decline over 30 days, 0.7% decline year to date, 31.0% decline over 1 year, 23.2% over 3 years and 39.7% over 5 years. Taken together, these figures give a mixed picture of how the market has treated...

If you are wondering whether Turning Point Brands at US$136.99 is priced for perfection or still offers value, you are in the right place. The stock has returned 1.1% over the past week, 13.1% over 30 days, 24.3% year to date and 95.6% over 1 year, while the 3 year return is very large and the 5 year return sits at 195.4%. Recent news coverage has largely focused on Turning Point Brands as a tobacco and related products company operating in a highly regulated industry, with investors paying...

If you have been wondering whether Hormel Foods at around US$25.60 is a bargain or a value trap, you are not alone. This article is built to help you size that up clearly. The stock has recent returns of 2.4% over 7 days, 4.0% over 30 days and 9.4% year to date, while the 1 year, 3 year and 5 year returns of 6.5%, 29.6% and 37.4% declines show a much tougher longer term picture. Recent coverage around Hormel Foods has focused on how a long established packaged food business is responding to...

Texas Roadhouse, Inc. recently reported fourth-quarter and full-year 2025 results showing higher revenue but lower net income year-over-year, while also updating investors on its completed US$120.00 million share repurchase program that retired 701,511 shares. Alongside these results, the Board approved a quarterly cash dividend of US$0.75 per share, payable on March 31, 2026 to shareholders of record on March 17, 2026, underscoring management’s continued emphasis on direct cash returns even...

Cadre Holdings (NYSE: CDRE) recently reported that over the past two years its revenue grew 13.4% annually and earnings per share increased 19.9% annually, both ahead of peers in the safety and survivability equipment market for first responders. This combination of faster revenue expansion and outsized earnings growth suggests Cadre may be capturing market share while improving profitability versus competitors. We’ll now explore how Cadre’s above-peer revenue and earnings growth could...

Richtech Robotics: Context for Recent Stock Performance Richtech Robotics (RR) has drawn attention after a recent stretch of weak trading, with the stock showing negative returns over the past week, month, and past 3 months. That price action has investors rechecking the story behind this US robotics player. See our latest analysis for Richtech Robotics. At a share price of $2.49, Richtech Robotics has seen momentum fade recently, with a 1 month share price return of 30.45% and a year to date...

This article is for readers wondering whether HCA Healthcare's share price still offers value after a strong run, or whether most of the opportunity is already priced in. The stock last closed at US$529.70, with a 7 day return of a 0.5% decline, a 30 day return of 8.5%, a year to date return of 12.6%, a 1 year return of 74.2%, a 3 year return of 117.1% and a 5 year return of 201.1%. Recent coverage of HCA Healthcare has focused on its role as a major US hospital operator and on how broader...

CRA International, Inc. recently reported fourth-quarter 2025 revenue of US$196.96 million and full-year revenue of US$751.58 million, alongside record annual net income of US$54.78 million and an ongoing quarterly dividend of US$0.57 per share. Along with setting new highs for annual revenue and profitability, CRA International raised its 2026 revenue outlook to US$785–805 million and expanded its share repurchase authorization by US$55 million, underscoring management’s emphasis on...

Why Eastman Chemical (EMN) is on investors’ radar Eastman Chemical (EMN) has drawn fresh attention after its recent share performance, with the stock showing mixed shorter term returns and a stronger move in the past 3 months. See our latest analysis for Eastman Chemical. At a share price of US$75.51, Eastman Chemical’s 30 day share price return of 8.93% and 90 day share price return of 21.89% contrast with a 1 year total shareholder return decline of 19.26%. This suggests recent momentum...

If you are wondering whether PG&E at around US$19.00 a share is giving you fair value or a margin of safety, you are not alone. This article is built to help you frame that question clearly. Over the short term the stock has posted returns of 3.5% over 7 days, 23.2% over 30 days, 16.8% year to date, 17.2% over 1 year and 17.6% over 3 years, with a 5 year return of 77.1% that many investors will want to weigh against current pricing. Recent coverage around PG&E has focused on how the utility...

Ginkgo Bioworks Holdings (DNA) is back in focus after reporting 2025 results that combined smaller losses and lower cash burn with a clear pivot toward robotics-powered autonomous labs and a planned biosecurity divestiture. See our latest analysis for Ginkgo Bioworks Holdings. The earnings release, biosecurity divestiture plan, and new autonomous lab contracts have coincided with heavy selling, including a 30.48% 1-day share price return decline and a 26.79% 7-day share price return decline...